Open original FDA record ↗Recall record
- FDA identifier
- Z-0174-2018
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA record creation date
- Nov 28, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Complaint of high amount of ceruloplasmin patient results below the reference range (< 20 mg/dL [0.2 g/L]. PROT1 CAL and corresponding PROT1 CON L, M, and H are inaccurately assigned for ceruloplasmin (CER).
Source facts
- Action
- Siemens issued an Urgent Medical Device Correction (UMDC) letter (PP-17-012.A.US, dated May 23, 2017) to US customers on May 23, 2017 and an Urgent Field Safety Notice (UFSN) to customers Outside the US in May 2017. Customers were instructed in the letter to use re-assigned CER values for the lots indicated of PROT1 CAL and PROT1 CON L, M, and H. In the US, the method of distribution is FEDEX and outside the US, the distribution is determined at the country level. Customers were requested to complete Effectiveness Check questionnaire attached to the UMDC/UFSN and return to Siemens within 30 days.
- Initiated
- 2017-05-23
- Root cause
- Nonconforming Material/Component
- Terminated
- 2018-03-30
- Distribution
- Worldwide Distribution - US (nationwide) Internationally to Austria, Australia, Belgium, Canada, France, Germany, Great Britain, Italy, Japan, Netherlands, Portugal, Slovakia, Spain, Switzerland and Republic of Korea South
- Recall number
- Z-0174-2018
- Recall status
- Terminated
- CDRH record ID
- 155944
- FDA record created
- 2017-11-28
- Recall event number
- 77381